Blue Owl Capital Holdings LP - 31 Dec 2024 SCHEDULE 13G/A Report for AEON Biopharma, Inc. Class A common stock, par value $0.001 per share (AEON)

Filing Manager
Blue Owl Capital Holdings LP
Reporting Manager
Blue Owl Capital Holdings LP
Security
AEON Biopharma, Inc. Class A common stock, par value $0.001 per share
Symbol
AEON
Shares outstanding
80,035,722 shares
Disclosed Ownership
3,049,361 shares
Ownership
3.8%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:09:36 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Blue Owl Capital Holdings LP disclosed 3.8% ownership in AEON Biopharma, Inc. Class A common stock, par value $0.001 per share (AEON) on 31 Dec 2024."

Quick Takeaways

  • Blue Owl Capital Holdings LP filed SCHEDULE 13G/A for AEON Biopharma, Inc. Class A common stock, par value $0.001 per share (AEON).
  • Disclosed ownership: 3.8%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 17:09.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Blue Owl Capital Holdings LP 3.8% 3,049,361 3,049,361 0 /s/ Karen Hager Karen Hager/Chief Compliance Officer

Sponsored